EP0388621A1 — Inhaler with regular complete emptying of the capsule
Assigned to Ph&t Srl Te Milaan Italie · Expires 1990-09-26 · 36y expired
What this patent protects
An inhaler (10) for administering medicaments in finely divided form contained in capsules (18) comprises a nebulization chamber (42) and a device (16) for piercing the capsule (18). That end surface of the nebulization chamber (42) containing the holes (48,49,50) for the dischar…
USPTO Abstract
An inhaler (10) for administering medicaments in finely divided form contained in capsules (18) comprises a nebulization chamber (42) and a device (16) for piercing the capsule (18). That end surface of the nebulization chamber (42) containing the holes (48,49,50) for the discharge of air laden with the finely divided medicament is shaped such that the capsule (18), when resting on it, does not impede air passage through any of the discharge holes (48,49,50). The nebulization chamber (42), at least in that part thereof closest to said discharge holes (48,49,50), tapers towards that end surface of the chamber (42) comprising the discharge holes (48,49,50).
Drugs covered by this patent
- Remodulin (TREPROSTINIL) · United Therap
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.